FDA Import Refusal 1FX-5033367-3/10002/1 — Roche Pharma AG

Roche Pharma AG — FEI 3002807206

The FDA refused shipment 1FX-5033367-3/10002/1 from Roche Pharma AG (Germany) on Aug 18, 2026. The refused product falls under Drugs and Biologics — ERLOTINIB HYDROCHLORIDE (ANTI-NEOPLASTIC - PART II). Cited charges: 118,75 This firm has 5 or more other import refusals on record.